Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU approval for teens after WHO declares health emergency
CEO Paul Chaplin told CNBC that the expanded approval for 12- to 17-year-olds would be crucial in tackling the latest outbreak.
CEO Paul Chaplin told CNBC that the expanded approval for 12- to 17-year-olds would be crucial in tackling the latest outbreak.
